BenevolentAI: Shareholder Letter December 2023 -December 28, 2023 at 01:01 am EST
Regulatory News: Posted to shareholders on 27 December 2023 Dear Shareholders AI is becoming an accepted and validated approach to drug discovery and development with long term structural...
Source: marketscreener.com